NCT03002623: A reported trial by National Cancer Institute (NCI)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03002623 |
|---|---|
| Title | A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 22, 2016 |
| Completion date | Feb. 12, 2018 |
| Required reporting date | Feb. 12, 2019, midnight |
| Actual reporting date | July 27, 2018 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |